The closing price of Fulcrum Therapeutics Inc. (NASDAQ: FULC) was $12.63 for the day, up 3.95% from the previous closing price of $12.15. In other words, the price has increased by $+0.48 from its previous closing price. On the day, 1060459 shares were traded. FULC stock price reached its highest trading level at $12.63 during the session, while it also had its lowest trading level at $12.00.
Our analysis of FULC’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 15.50 and its Current Ratio is at 15.50. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, Goldman on November 15, 2022, initiated with a Buy rating and assigned the stock a target price of $11.
On March 08, 2022, Oppenheimer started tracking the stock assigning a Outperform rating and target price of $33.
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 13 when Gould Robert J sold 6,766 shares for $15.00 per share. The transaction valued at 101,490 led to the insider holds 499,864 shares of the business.
RA CAPITAL MANAGEMENT, L.P. bought 180,703 shares of FULC for $1,314,806 on Jan 04. The 10% Owner now owns 9,686,628 shares after completing the transaction at $7.28 per share. On Dec 27, another insider, RA CAPITAL MANAGEMENT, L.P., who serves as the 10% Owner of the company, bought 4,089 shares for $5.99 each. As a result, the insider paid 24,510 and bolstered with 9,505,925 shares of the company.
For the stock, the TTM Price-to-Sale (P/S) ratio is 70.02 while its Price-to-Book (P/B) ratio in mrq is 2.64.
Stock Price History:
Over the past 52 weeks, FULC has reached a high of $24.79, while it has fallen to a 52-week low of $3.21. The 50-Day Moving Average of the stock is 7.79, while the 200-Day Moving Average is calculated to be 7.88.
FULC traded an average of 713.34K shares per day over the past three months and 1.33M shares per day over the past ten days. A total of 61.67M shares are outstanding, with a floating share count of 58.56M. Insiders hold about 4.68% of the company’s shares, while institutions hold 85.94% stake in the company. Shares short for FULC as of Oct 13, 2022 were 3.46M with a Short Ratio of 3.58M, compared to 3.88M on Sep 14, 2022. Therefore, it implies a Short% of Shares Outstanding of 6.66% and a Short% of Float of 8.88%.
The firm’s stock currently is rated by 8 analysts. On average, analysts expect EPS of -$0.62 for the current quarter, with a high estimate of -$0.47 and a low estimate of -$0.74, while EPS last year was -$0.57. The consensus estimate for the next quarter is -$0.6, with high estimates of -$0.39 and low estimates of -$0.77.
Analysts are recommending an EPS of between -$2.24 and -$2.98 for the fiscal current year, implying an average EPS of -$2.66. EPS for the following year is -$2.39, with 8 analysts recommending between -$1.26 and -$3.44.
A total of 8 analysts have provided revenue estimates for FULC’s current fiscal year. The highest revenue estimate was $12.5M, while the lowest revenue estimate was $4.9M, resulting in an average revenue estimate of $8.93M. In the same quarter a year ago, actual revenue was $19.16M, down -53.40% from the average estimate.